HUP9900386A2 - Fenoxi-piridin-származékok alkalmazása szívelégtelenség kezelésére alkalmas gyógyszerkészítmények előállítására - Google Patents

Fenoxi-piridin-származékok alkalmazása szívelégtelenség kezelésére alkalmas gyógyszerkészítmények előállítására

Info

Publication number
HUP9900386A2
HUP9900386A2 HU9900386A HUP9900386A HUP9900386A2 HU P9900386 A2 HUP9900386 A2 HU P9900386A2 HU 9900386 A HU9900386 A HU 9900386A HU P9900386 A HUP9900386 A HU P9900386A HU P9900386 A2 HUP9900386 A2 HU P9900386A2
Authority
HU
Hungary
Prior art keywords
phenoxy
heart failure
dimethyl
pharmaceutical compositions
compositions suitable
Prior art date
Application number
HU9900386A
Other languages
English (en)
Inventor
Yuhpyng Liang Chen
Anthony Andrea Fossa
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of HU9900386D0 publication Critical patent/HU9900386D0/hu
Publication of HUP9900386A2 publication Critical patent/HUP9900386A2/hu
Publication of HUP9900386A3 publication Critical patent/HUP9900386A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya 4-(1-etil-prőpőxi)-3,6-dimetil-2-(2,4,6-trimetil-fenőxi)-piridin vagy (3,6-dimetil-2-(2,4,6-trimetil-fenőxi)-piridin-4-il)-(1-etil-prőpil)-amin vagy elővegyületük vagy gyógyászatilagelfőgadható sójűk alkalmazása emlősök szívelégtelenségének kezelésérealkalmas gyógyszerkészítmény előállítására. A találmány őlyangyógyszerkészítményre is vőnatkőzik, amely a 4-(1-etil-prőpőxi)-3,6-dimetil-2-(2,4,6-trimetil-fenőxi)-piridin vagy (3,6-dimetil-2-(2,4,6-trimetil-fenőxi)-piridin-4-il)-(1-etil-prőpil)-amin mellett valamelypangásős szívelégtelenség kezelésére alkalmas gyógyszert ésgyógyászatilag elfőgadható hőrdőzót vagy hígítószert is tartalmaz. Agyógyszerkészítményt az egyes kőmpőnenseket tartalmazó kit főrmában iskiszerelik. ŕ
HU9900386A 1998-02-17 1999-02-16 Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure HUP9900386A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7493498P 1998-02-17 1998-02-17

Publications (3)

Publication Number Publication Date
HU9900386D0 HU9900386D0 (en) 1999-04-28
HUP9900386A2 true HUP9900386A2 (hu) 1999-11-29
HUP9900386A3 HUP9900386A3 (en) 1999-12-28

Family

ID=22122537

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900386A HUP9900386A3 (en) 1998-02-17 1999-02-16 Use of phenoxy-pyridine derivatives for producing pharmaceutical compositions suitable for treating heart failure

Country Status (28)

Country Link
US (1) US6043260A (hu)
EP (1) EP0951906A1 (hu)
JP (1) JPH11292766A (hu)
KR (1) KR19990072616A (hu)
CN (1) CN1231176A (hu)
AP (1) AP9901464A0 (hu)
AR (1) AR017723A1 (hu)
AU (1) AU1732999A (hu)
BG (1) BG103180A (hu)
BR (1) BR9900653A (hu)
CA (1) CA2262252C (hu)
EA (1) EA199900124A3 (hu)
GT (1) GT199900015A (hu)
HR (1) HRP990054A2 (hu)
HU (1) HUP9900386A3 (hu)
ID (1) ID23218A (hu)
IL (1) IL128531A0 (hu)
IS (1) IS4975A (hu)
MA (1) MA26608A1 (hu)
NO (1) NO990722L (hu)
OA (1) OA10976A (hu)
PA (1) PA8467401A1 (hu)
PE (1) PE20000266A1 (hu)
PL (1) PL331507A1 (hu)
SG (1) SG81261A1 (hu)
TN (1) TNSN99024A1 (hu)
TR (1) TR199900328A2 (hu)
ZA (1) ZA991220B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6403599B1 (en) 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
US7067664B1 (en) 1995-06-06 2006-06-27 Pfizer Inc. Corticotropin releasing factor antagonists
US6956047B1 (en) 1995-06-06 2005-10-18 Pfizer Inc. Corticotropin releasing factor antagonists
US6387894B1 (en) * 1999-06-11 2002-05-14 Pfizer Inc. Use of CRF antagonists and renin-angiotensin system inhibitors
AU3885901A (en) * 1999-09-21 2001-04-24 Emory University Methods and compositions for treating platelet-related disorders
BR0107662A (pt) * 2000-01-18 2002-11-19 Pfizer Prod Inc Antagonistas do fator de liberação de corticotropina
GB0027410D0 (en) * 2000-11-09 2000-12-27 Pfizer Ltd Mutual prodrug of amlodipine and atorvastatin
US6737430B2 (en) 2000-11-09 2004-05-18 Pfizer, Inc. Mutual prodrug of amlodipine and atorvastatin
US6992087B2 (en) 2001-11-21 2006-01-31 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
AU2003215379A1 (en) 2002-02-22 2003-09-09 Pharmacia And Upjohn Company Substituted pyrimidinones and pyrimidinthiones
BR0308391A (pt) * 2002-03-13 2005-01-11 Pharmacia & Upjohn Co Llc Derivados de pirazolo(1,5-a)piridina como moduladores neurotransmissores
EP1499599A1 (en) * 2002-04-26 2005-01-26 Pharmacia & Upjohn Company LLC Substituted pyrazine derivatives
EP1539736A1 (en) * 2002-09-12 2005-06-15 Pharmacia & Upjohn Company LLC Substituted 1,4-pyrazine derivatives
AR041470A1 (es) * 2002-10-17 2005-05-18 Upjohn Co Compuestos de pirrolo (1,2 - b) piridazina y sus usos
MXPA05005408A (es) * 2002-11-21 2005-08-03 Pharmacia & Upjohn Co Llc Compuestos de pirazina como moduladores de factor de liberacion de corticotropina.
EP1620428A1 (en) * 2003-04-23 2006-02-01 Pharmacia & Upjohn Company LLC Substituted pyrimidinones and pyrimidinthiones as crf antagonists
EP1622911A2 (en) * 2003-05-07 2006-02-08 Pharmacia & Upjohn Company LLC Pyrrolo[1,2-b]pyridazine compounds and their use as crf-1 receptor antagonists
MXPA05012087A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Nuevas pirazinonas como antagonistas del receptor crf1.
JP2006525993A (ja) * 2003-05-09 2006-11-16 ファルマシア・アンド・アップジョン・カンパニー・エルエルシー Ｃｒｆ１受容体拮抗剤である化合物
MXPA05012081A (es) * 2003-05-09 2006-02-22 Pharmacia & Upjohn Co Llc Derivados de pirimidina sustituidos.
WO2005089639A2 (en) * 2004-03-16 2005-09-29 Talarico M D Matthew T Method for vascular dysregulation
US20060211710A1 (en) * 2005-03-17 2006-09-21 Pfizer Inc Substituted aryl 1,4-pyrazine derivatives
US8338441B2 (en) * 2009-05-15 2012-12-25 Gilead Sciences, Inc. Inhibitors of human immunodeficiency virus replication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW574214B (en) * 1994-06-08 2004-02-01 Pfizer Corticotropin releasing factor antagonists
US6403599B1 (en) * 1995-11-08 2002-06-11 Pfizer Inc Corticotropin releasing factor antagonists
EP0795327A1 (en) * 1996-03-13 1997-09-17 Pfizer Inc. Use of Amlodipine for the treatment and prophylaxis of congestive cardiac failure of non-ischaemic origin

Also Published As

Publication number Publication date
AR017723A1 (es) 2001-09-12
TR199900328A2 (xx) 1999-10-21
PE20000266A1 (es) 2000-04-07
NO990722L (no) 1999-08-18
BR9900653A (pt) 2000-10-17
TNSN99024A1 (fr) 2005-11-10
IL128531A0 (en) 2000-01-31
SG81261A1 (en) 2001-06-19
KR19990072616A (ko) 1999-09-27
AP9901464A0 (en) 1999-03-31
CA2262252A1 (en) 1999-08-17
PL331507A1 (en) 1999-08-30
HRP990054A2 (en) 2000-02-29
GT199900015A (es) 2000-07-26
CN1231176A (zh) 1999-10-13
ZA991220B (en) 2000-08-16
AU1732999A (en) 1999-09-02
IS4975A (is) 1999-08-18
OA10976A (en) 2001-11-05
PA8467401A1 (es) 2000-09-29
EP0951906A1 (en) 1999-10-27
HUP9900386A3 (en) 1999-12-28
CA2262252C (en) 2006-01-10
HU9900386D0 (en) 1999-04-28
JPH11292766A (ja) 1999-10-26
EA199900124A2 (ru) 1999-08-26
ID23218A (id) 2000-03-30
BG103180A (bg) 1999-09-30
EA199900124A3 (ru) 1999-12-29
US6043260A (en) 2000-03-28
MA26608A1 (fr) 2004-12-20
NO990722D0 (no) 1999-02-16

Similar Documents

Publication Publication Date Title
HUP9900386A2 (hu) Fenoxi-piridin-származékok alkalmazása szívelégtelenség kezelésére alkalmas gyógyszerkészítmények előállítására
CA2093798A1 (en) Pyridine and pyridine n-oxide derivatives of diaryl methyl piperidines or piperazines, and compositions and methods of use thereof
AU9189301A (en) Use of substituted imidazo(1,2-A)pyridine-, imidazo(1,2-A)pyrimidine and imidazo(1,2-A)pyrazine-3-YL-amine derivatives for producing NOS-inhibiting medicaments
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
GEP20063895B (en) Platinum derivative pharmaceutical formulations
MY128659A (en) Novel aminodicarboxylic acid derivatives having pharmaceutical properties
BR0215312A (pt) Uso de um composto, método para inibir a aurora quinase em um animal de sangue quente, composto, composição farmacêutica, e, processo para a preparação de um composto
EP1308439A8 (en) Proline derivatives and use thereof as drugs
YU69991A (sh) Derivati piridina
MY124122A (en) Heterocyclic derivatives
DE60222137D1 (de) Zuckerderivate von hydromorphon, dihydromorphin und dihydroisomorphin, zusammensetzungen davon und verwendung zur vorbeugung und behandlung von schmerzen
HK1067560A1 (en) Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
AU4048989A (en) Alkoxy-4(1h)-pyridone derivatives, processes for preparing them and their use as drugs
BG105459A (en) Pharmaceutical moxifloxacin preparation
WO2001051051A3 (en) Agents, such as nicotinamide or cadpr for the treatment of skin disorders
GEP20022763B (en) 2-(3,5-Bis-Trifluoromethyl-Phenyl)-N-Methyl-N-(6-Morpholin-4-Yl-4-O-Tolyl-Pyridin-3-Yl)-Isobutyramide, Method for its Production and Medicament Containing the Same for Treatment of the Diseases Caused by NK-1 Receptor
IS7006A (is) Tvívetnis 3-piperidínóprópíófenon og lyf sem innihalda téð efnasambönd
MD523G2 (ro) Derivaţi noi ai triazolpirimidinei, antagonişti ai receptorilor angiotensinei II, procedee de preparare a lor, compoziţii farmaceutice ce le conţin
BG106155A (en) Novel derivatives and analogues of galanthamin
BG60101A3 (en) Method for preparing of 4-fluoro-2-[[(4-methoxy-2-pyridinyl)methyl]thionil]-1h-benzimidazo le
BG105342A (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases
EP1411956B8 (en) Use of oversulfated polysaccharides as inhibitors of hiv
HUP0401115A3 (en) 4-(benzylideneamino)-3-(methylsulfanyl)-4h-[1,2,4]triazin-5-one derivatives having a pde iv-inhibiting and tnf-antagonistic action for the treatment of heart diseases and allergies, process for their preparation and pharmaceutical compositions ...
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel